Acute Repetitive Seizures Market
According to Intent Market Research, the Acute Repetitive Seizures Market is expected to grow from USD 1.7 billion in 2023 at a CAGR of 9.8% to touch USD 3.2 billion by 2030. The Acute Repetitive Seizures Market is dominated by key players such as, Neurelis, Inc., UCB Pharma, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, and Lundbeck A/S.